Additional file 2: of The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

Additional file 2: Table S2. of Decision support systems for incurable non-small cell lung cancer: a systematic review

D. RĂŠvĂŠsz (4485874)
E. Engelhardt (4485871)
J. Tamminga (4485880)
F. Schramel (4485859)
B. Onwuteaka-Philipsen (4485868)
E. van de Garde (4485865)
E. Steyerberg (4485856)
E. Jansma (4485862)
H. De Vet (4485877)
V. CoupĂŠ (4485853)

October 2017

Overview and quality assessment of decision support systems for incurable patients with (initial or ...

Additional file 3: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Figure S1. Hierarchy of preferred methodology for generation of HSUVs for different HTA agencies. (P...

Additional file 2: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Table S2. Listing of first-line mNSCLC studies with utility data excluded at second pass [80â100]....

Additional file 1: of The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

David Campbell (23769)
Ken OâDay (6011009)
Nadine Hertel (6011000)
John Penrod (6011003)
Melinda Manley Daumont (6011006)
Michael Lees (117739)

November 2018

Comprehensive literature search results. Diagram summarizing results of the comprehensive literature...

Additional file 1: of Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Adrian Vickers (6590708)
Katherine Winfree (6590711)
Gebra Cuyun Carter (838616)
Urpo Kiiskinen (838621)
Min-Hua Jen (6590714)
Donald Stull (3409508)
James Kaye (5168222)
David Carbone (622010)

April 2019

Risk of bias assessment, study characteristics, sensitivity analyses, subgroup results and Bayesian ...

Additional file 2: of Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

Anna Rich (5998079)
David Baldwin (371430)
Inmaculada Alfageme (322042)
Paul Beckett (1293276)
Thierry Berghmans (5998091)
Stephen Brincat (5998094)
Otto Burghuber (5998097)
Alexandru Corlateanu (5998100)
Tanja Cufer (4928008)
Ronald Damhuis (5998103)
Edvardas Danila (5998106)
Joanna Domagala-Kulawik (5998109)
Stefano Elia (5998112)
Mina Gaga (2938956)
Tuncay Goksel (5998115)
Bogdan Grigoriu (64882)
Gunnar Hillerdal (448781)
Rudolf Huber (4831485)
Erik Jakobsen (5998118)
Steinn Jonsson (372293)
Dragana Jovanovic (3634732)
Elena Kavcova (5998121)
Assia Konsoulova (5998124)
Tanel Laisaar (5998127)
Riitta Makitaro (5998130)
Bakir Mehic (5998133)
Robert Milroy (5998136)
Judit Moldvay (843831)
Ross Morgan (5998139)
Milda Nanushi (5998142)
Marianne Paesmans (362728)
Paul Putora (5998145)
Miroslav Samarzija (3469178)
Arnaud Scherpereel (41882)
Marc Schlesser (1643557)
Jean-Paul Sculier (5998151)
Jana Skrickova (5998154)
Renato Sotto-Mayor (5998160)
Trond-Eirik Strand (5998163)
Paul Van Schil (5959143)
Torsten-Gerriet Blum (5998166)

November 2018

Additional information provided by lung cancer physicians regarding thoracic oncology data collectio...

Additional file 1: of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Supplementary Method. Search strategies for PubMed, EMBASE, and Cochrane database. (PDF 314 kb

Additional file 3 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...

Additional file 6: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Forest plots of mean difference in RMS and mean difference in total survival (Weibull models). (DOCX...

Additional file 1: of A global perspective on coal-fired power plants and burden of lung cancer

Cheng-Kuan Lin (4470712)
Ro-Ting Lin (4470709)
Tom Chen (2035723)
Corwin Zigler (6271445)
Yaguang Wei (2269066)
David Christiani (72443)

January 2019

Table S1. Countries included in the analysis, by geographical region a (NÂ =â83). Table S3. Relati...

Additional file 2: of An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values

Ashley Carter (3199737)
Beverly Delarosa (3495977)
Hannah Hur (3495980)

November 2015

Analysis of a comparison of the percentage differences in research funding (Y-axis) and years of lif...

Additional file 1: of The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer

Yaxiong Zhang (629676)
Lianpeng Chang (433830)
Yunpeng Yang (522293)
Wenfeng Fang (172072)
Yanfang Guan (149221)
Aiwei Wu (420942)
Shaodong Hong (629679)
Huaqiang Zhou (6193214)
Gang Chen (107840)
Xi Chen (35903)
Shen Zhao (2583850)
Qiufan Zheng (6193217)
Hui Pan (149683)
Lanjun Zhang (449343)
Hao Long (154818)
Haoxian Yang (6193220)
Xin Wang (91924)
Zhesheng Wen (6193223)
Junye Wang (384072)
Hong Yang (37298)
Xuefeng Xia (235389)
Yuanyuan Zhao (109963)
Xue Hou (285519)
Yuxiang Ma (522295)
Ting Zhou (38572)
Zhonghan Zhang (2175106)
Jianhua Zhan (3927716)
Yan Huang (46805)
Hongyun Zhao (285512)
Ningning Zhou (3218982)
Xin Yi (180644)
Li Zhang (8200)

April 2019

Table S1. Clinical characteristics of the enrolled 32 NSCLC patients. Table S2. List of target regio...

Additional file 1 of Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

Yimin Wang (724389)
Chuling Li (7466345)
Zimu Wang (10338749)
Zhaofeng Wang (1428373)
Ranpu Wu (14071903)
Ying Wu (19057)
Yong Song (286107)
Hongbing Liu (291584)

November 2022

Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...

Additional file 1: of Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Carsten Nieder (75550)
Matthias Guckenberger (41734)
Laurie Gaspar (6370616)
Chad Rusthoven (6370619)
Dirk Ruysscher (6370622)
Arjun Sahgal (3772702)
Timothy Nguyen (1415479)
Anca Grosu (4637779)
Minesh Mehta (186572)

February 2019

Figure S1. Representative computed tomography and magnetic resonance imaging scans distributed to th...

Additional file 8: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Association of survival estimates and reported medians and hazard ratios. (DOCX 32 kb

Additional file 2: Table S2. of Decision support systems for incurable non-small cell lung cancer: a systematic review

D. RĂŠvĂŠsz (4485874)
E. Engelhardt (4485871)
J. Tamminga (4485880)
F. Schramel (4485859)
B. Onwuteaka-Philipsen (4485868)
E. van de Garde (4485865)
E. Steyerberg (4485856)
E. Jansma (4485862)
H. De Vet (4485877)
V. CoupĂŠ (4485853)

October 2017

Overview and quality assessment of decision support systems for incurable patients with (initial or ...

Additional file 3: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Figure S1. Hierarchy of preferred methodology for generation of HSUVs for different HTA agencies. (P...

Additional file 2: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Table S2. Listing of first-line mNSCLC studies with utility data excluded at second pass [80â100]....

Additional file 1: of The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

David Campbell (23769)
Ken OâDay (6011009)
Nadine Hertel (6011000)
John Penrod (6011003)
Melinda Manley Daumont (6011006)
Michael Lees (117739)

November 2018

Comprehensive literature search results. Diagram summarizing results of the comprehensive literature...

Additional file 1: of Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Adrian Vickers (6590708)
Katherine Winfree (6590711)
Gebra Cuyun Carter (838616)
Urpo Kiiskinen (838621)
Min-Hua Jen (6590714)
Donald Stull (3409508)
James Kaye (5168222)
David Carbone (622010)

April 2019

Risk of bias assessment, study characteristics, sensitivity analyses, subgroup results and Bayesian ...

Additional file 2: of Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

Anna Rich (5998079)
David Baldwin (371430)
Inmaculada Alfageme (322042)
Paul Beckett (1293276)
Thierry Berghmans (5998091)
Stephen Brincat (5998094)
Otto Burghuber (5998097)
Alexandru Corlateanu (5998100)
Tanja Cufer (4928008)
Ronald Damhuis (5998103)
Edvardas Danila (5998106)
Joanna Domagala-Kulawik (5998109)
Stefano Elia (5998112)
Mina Gaga (2938956)
Tuncay Goksel (5998115)
Bogdan Grigoriu (64882)
Gunnar Hillerdal (448781)
Rudolf Huber (4831485)
Erik Jakobsen (5998118)
Steinn Jonsson (372293)
Dragana Jovanovic (3634732)
Elena Kavcova (5998121)
Assia Konsoulova (5998124)
Tanel Laisaar (5998127)
Riitta Makitaro (5998130)
Bakir Mehic (5998133)
Robert Milroy (5998136)
Judit Moldvay (843831)
Ross Morgan (5998139)
Milda Nanushi (5998142)
Marianne Paesmans (362728)
Paul Putora (5998145)
Miroslav Samarzija (3469178)
Arnaud Scherpereel (41882)
Marc Schlesser (1643557)
Jean-Paul Sculier (5998151)
Jana Skrickova (5998154)
Renato Sotto-Mayor (5998160)
Trond-Eirik Strand (5998163)
Paul Van Schil (5959143)
Torsten-Gerriet Blum (5998166)

November 2018

Additional information provided by lung cancer physicians regarding thoracic oncology data collectio...

Additional file 1: of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Supplementary Method. Search strategies for PubMed, EMBASE, and Cochrane database. (PDF 314 kb

Additional file 3 of Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Yixin Zhou (6113774)
Chen Chen (6544)
Xuanye Zhang (6113777)
Sha Fu (445944)
Cong Xue (285516)
Yuxiang Ma (522295)
Wenfeng Fang (172072)
Yunpeng Yang (522293)
Xue Hou (285519)
Yan Huang (46805)
Hongyun Zhao (285512)
Shaodong Hong (629679)
Li Zhang (8200)

December 2018

Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...

Additional file 6: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Forest plots of mean difference in RMS and mean difference in total survival (Weibull models). (DOCX...

Additional file 1: of A global perspective on coal-fired power plants and burden of lung cancer

Cheng-Kuan Lin (4470712)
Ro-Ting Lin (4470709)
Tom Chen (2035723)
Corwin Zigler (6271445)
Yaguang Wei (2269066)
David Christiani (72443)

January 2019

Table S1. Countries included in the analysis, by geographical region a (NÂ =â83). Table S3. Relati...

Additional file 2: of An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values

Ashley Carter (3199737)
Beverly Delarosa (3495977)
Hannah Hur (3495980)

November 2015

Analysis of a comparison of the percentage differences in research funding (Y-axis) and years of lif...

Additional file 1: of The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer

Yaxiong Zhang (629676)
Lianpeng Chang (433830)
Yunpeng Yang (522293)
Wenfeng Fang (172072)
Yanfang Guan (149221)
Aiwei Wu (420942)
Shaodong Hong (629679)
Huaqiang Zhou (6193214)
Gang Chen (107840)
Xi Chen (35903)
Shen Zhao (2583850)
Qiufan Zheng (6193217)
Hui Pan (149683)
Lanjun Zhang (449343)
Hao Long (154818)
Haoxian Yang (6193220)
Xin Wang (91924)
Zhesheng Wen (6193223)
Junye Wang (384072)
Hong Yang (37298)
Xuefeng Xia (235389)
Yuanyuan Zhao (109963)
Xue Hou (285519)
Yuxiang Ma (522295)
Ting Zhou (38572)
Zhonghan Zhang (2175106)
Jianhua Zhan (3927716)
Yan Huang (46805)
Hongyun Zhao (285512)
Ningning Zhou (3218982)
Xin Yi (180644)
Li Zhang (8200)

April 2019

Table S1. Clinical characteristics of the enrolled 32 NSCLC patients. Table S2. List of target regio...

Additional file 1 of Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

Yimin Wang (724389)
Chuling Li (7466345)
Zimu Wang (10338749)
Zhaofeng Wang (1428373)
Ranpu Wu (14071903)
Ying Wu (19057)
Yong Song (286107)
Hongbing Liu (291584)

November 2022

Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...

Additional file 1: of Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Carsten Nieder (75550)
Matthias Guckenberger (41734)
Laurie Gaspar (6370616)
Chad Rusthoven (6370619)
Dirk Ruysscher (6370622)
Arjun Sahgal (3772702)
Timothy Nguyen (1415479)
Anca Grosu (4637779)
Minesh Mehta (186572)

February 2019

Figure S1. Representative computed tomography and magnetic resonance imaging scans distributed to th...

Additional file 8: of Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials

Martin Connock (159426)
Xavier Armoiry (3413465)
Alexander Tsertsvadze (182148)
G. Melendez-Torres (3476636)
Pamela Royle (371969)
Lazaros Andronis (4038071)
Aileen Clarke (470453)

April 2019

Association of survival estimates and reported medians and hazard ratios. (DOCX 32 kb

Additional file 2: Table S2. of Decision support systems for incurable non-small cell lung cancer: a systematic review

D. RĂŠvĂŠsz (4485874)
E. Engelhardt (4485871)
J. Tamminga (4485880)
F. Schramel (4485859)
B. Onwuteaka-Philipsen (4485868)
E. van de Garde (4485865)
E. Steyerberg (4485856)
E. Jansma (4485862)
H. De Vet (4485877)
V. CoupĂŠ (4485853)

October 2017

Overview and quality assessment of decision support systems for incurable patients with (initial or ...

Additional file 3: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Figure S1. Hierarchy of preferred methodology for generation of HSUVs for different HTA agencies. (P...

Additional file 2: of Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Noman Paracha (3091284)
Ahmed Abdulla (497170)
Katherine MacGilchrist (5744387)

September 2018

Table S2. Listing of first-line mNSCLC studies with utility data excluded at second pass [80â100]....

Additional file 2: of The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

Abstract

Extracted data

Additional file 2: of The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

Abstract

Extracted data

Related items

Related items